(Q38848272)
English
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts
scientific article published on 3 February 2010
Statements
1 reference
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts (English)
1 reference
C Kityo
1 reference
P Mugyenyi
1 reference
D M Gibb
1 reference
A S Walker
1 reference
P Munderi
1 reference
A G Babiker
1 reference
F Ssali
1 reference
A Reid
1 reference
J H Darbyshire
1 reference
C F Gilks
1 reference
DART/NORA trial teams
1 reference
3 February 2010
1 reference
1 reference
11
1 reference
5
1 reference
334-344
1 reference
Identifiers
1 reference
1 reference